-
Cost-Effectiveness Analysis of First-Line Tremelimumab Plus Durvalumab Versus Sorafenib in Unresectable Hepatocellular Carcinoma
Mar 10, 2025, 14:00 PM -
Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation
Mar 10, 2025, 14:00 PM -
Leveraging Social Media Listening and AI: Topic Modeling and RAG Approaches to Analyse Pet Owners' Perspectives on Nonsteroidal Anti-Inflammatory Drugs in Animal Health
Mar 10, 2025, 14:00 PM -
A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals
Mar 10, 2025, 14:00 PM -
Development and Validation of a Machine Learning-based screening Algorithm to Predict High Risk of Hepatitis C Infection
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Tisagenlecleucel for Third-Line Treatment With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization (HCRU) and Costs of Poly(ADP-ribose) Polymerase Inhibitors (PARPi) as First-Line Maintenance (1LM) Treatment for Ovarian Cancer (OC)
Mar 10, 2025, 14:00 PM -
Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis
Mar 10, 2025, 14:00 PM -
Economic Burden of Hwabyeong in South Korea: An Analysis of Direct, Non-Medical, and Indirect Costs
Mar 10, 2025, 14:00 PM -
Systematic Review of Secondary Primary Malignancies (SPMs) in Patients Treated with Chimeric Antigen Receptor T-cell (CAR-T) Therapies
Mar 10, 2025, 14:00 PM -
Addressing Neighborhood-Level Opioid Data Gaps: Development of an Interactive Dashboard for Prescription Trends and Buprenorphine Access in California
Mar 10, 2025, 14:00 PM -
Impact of COVID-19 on Quality of Life and Work Productivity Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Interim Analysis of a Nationwide Longitudinal Study
Mar 10, 2025, 14:00 PM -
Use of Clinical Outcome Assessments in Specialty Drug Coverage Policies
Mar 10, 2025, 14:00 PM -
Relationships Between ICER Clinical Evidence Ratings and FDA Approval Decisions
Mar 10, 2025, 14:00 PM -
Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews
Mar 10, 2025, 14:00 PM -
Developing a Large Language Model-Based Simulation for P&T Committees: Methodology and Inputs for Realistic Dynamics
Mar 10, 2025, 14:00 PM -
A Comprehensive Review of Real-World Evidence (RWE) Use in Submissions to Canada's Drug Agency (CDA)
Mar 10, 2025, 14:00 PM -
Use of Artificial Intelligence for Rapid Epidemiology Reviews With Pooled Prevalence and Incidence Estimates
Mar 10, 2025, 14:00 PM -
Augmenting Race and Ethnicity in a Real-World Oncology Cohort Using the Bayesian Improved Surname Geocoding Methodology
Mar 10, 2025, 14:00 PM -
A Reduction in Prosthetic Joint Infection and Surgical Time. Evidence from a Large US Database Study for OR3O Implant System in Hip Revision.
Mar 10, 2025, 14:00 PM
